Relay Therapeutics
RLAY
RLAY
161 hedge funds and large institutions have $2.76B invested in Relay Therapeutics in 2022 Q3 according to their latest regulatory filings, with 31 funds opening new positions, 70 increasing their positions, 29 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
37% more capital invested
Capital invested by funds: $2.02B → $2.76B (+$742M)
9% more funds holding
Funds holding: 148 → 161 (+13)
8.21% less ownership
Funds ownership: 110.99% → 102.78% (-8.2%)
Holders
161
Holding in Top 10
7
Calls
$7.22M
Puts
$1.78M
Top Buyers
| 1 | +$28.2M | |
| 2 | +$16.9M | |
| 3 | +$13.8M | |
| 4 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
+$13.5M |
| 5 |
Goldman Sachs
New York
|
+$10.4M |
Top Sellers
| 1 | -$31.1M | |
| 2 | -$30.8M | |
| 3 | -$24.8M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$16.5M |
| 5 |
BC
Boxer Capital
San Diego,
California
|
-$11.2M |